Lifecore Biomedical Inc (LFCR)
5.84
+0.06
(+1.04%)
USD |
NASDAQ |
May 31, 16:00
5.835
0.00 (0.00%)
After-Hours: 20:00
Lifecore Biomedical Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
May 31, 2023 | 0.00 |
February 28, 2023 | 0.178M |
November 30, 2022 | -5.00M |
August 31, 2022 | |
May 31, 2022 | 0.00 |
February 28, 2022 | 0.00 |
November 30, 2021 | 0.00 |
August 31, 2021 | |
May 31, 2021 | |
February 28, 2021 | |
November 30, 2020 | |
August 31, 2020 | |
May 31, 2020 | 0.00 |
February 29, 2020 | 0.00 |
November 30, 2019 | -0.03M |
August 31, 2019 | |
May 31, 2019 | -0.097M |
February 28, 2019 | -0.23M |
November 30, 2018 | 0.00 |
August 31, 2018 | |
May 31, 2018 | -0.055M |
February 28, 2018 | 0.00 |
November 30, 2017 | 0.00 |
August 31, 2017 | -0.001M |
May 31, 2017 | -0.473M |
Date | Value |
---|---|
February 28, 2017 | -0.04M |
November 30, 2016 | -0.095M |
August 31, 2016 | -0.098M |
May 31, 2016 | -0.04M |
February 29, 2016 | -0.174M |
November 30, 2015 | -0.067M |
August 31, 2015 | -0.041M |
May 31, 2015 | -0.012M |
February 28, 2015 | -0.01M |
November 30, 2014 | -0.097M |
August 31, 2014 | -0.003M |
May 31, 2014 | -0.151M |
February 28, 2014 | -0.894M |
November 30, 2013 | -1.003M |
August 31, 2013 | -0.25M |
May 31, 2013 | -2.031M |
February 28, 2013 | -0.734M |
November 30, 2012 | -0.449M |
August 31, 2012 | -0.202M |
May 31, 2012 | 0.029M |
February 29, 2012 | 0.202M |
November 30, 2011 | 4.714M |
August 31, 2011 | 0.00 |
May 31, 2011 | 0.00 |
February 28, 2011 | -0.017M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-5.00M
Minimum
Nov 2022
0.178M
Maximum
Feb 2023
-0.5391M
Average
--
Median
Feb 2020
Stock Buybacks (Quarterly) Benchmarks
Aquestive Therapeutics Inc | -82.10M |
SELLAS Life Sciences Group Inc | -26.55M |
ADMA Biologics Inc | -- |
Relmada Therapeutics Inc | -- |
Jaguar Health Inc | -12.49M |